Metformin vs Nivolumab
Metformin vs Nivolumab: Overview
This comparison examines the pharmacological differences between Metformin and Nivolumab.
Mechanism of Action
Metformin: Activates AMP-activated protein kinase, decreasing hepatic glucose production.
Nivolumab: Fully human anti-PD-1 IgG4 monoclonal antibody restoring T-cell anti-tumor activity.
Pharmacokinetics
Half-life: Metformin — 4-9 hours; Nivolumab — 27 days.
Chemical Properties
Molecular Formula: Metformin — C4H11N5.
Molecular Weight: Metformin — 129.1640 g/mol.
Type: Metformin — Small molecule; Nivolumab — Antibody.